Business, energy, technology, markets and global industry news from Business News Today

Cell Q

PharmaDeviceNews Cell Q
Automated cell therapy manufacturing could help Cellares and Papillon Therapeutics advance PPL-001 toward clinical development for Friedreich’s ataxia. Representative image.
Pharma & Biotech

Can Cellares automation move Papillon’s PPL-001 closer to a Friedreich’s ataxia trial?

Cellares will automate PPL-001 manufacturing for Friedreich’s ataxia, but IND-enabling work and human evidence remain ahead.

Read More
Cellares and Sonoma Biotherapeutics are collaborating to automate manufacturing of the investigational SBT-77-7101 engineered Treg cell therapy on the Cell Shuttle platform. Representative image.
Pharma & Biotech

Can engineered Treg therapy scale? Cellares and Sonoma begin a crucial manufacturing test

Cellares will automate SBT-77-7101 manufacturing as Sonoma Biotherapeutics prepares its CAR-Treg program for larger clinical trials.

Read More
Cellares FDA PreCheck selection puts automated cell therapy manufacturing under early review
Pharma & Biotech

Cellares enters FDA PreCheck as Cell Shuttle moves from automation promise to regulatory proof

Find out how Cellares’ FDA PreCheck selection could reshape automated cell therapy manufacturing while leaving product approval risks intact.

Read More